Literature DB >> 7668821

Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin.

A Ljunggren1, D Duggan, E McNally, K B Boylan, C H Gama, L M Kunkel, E P Hoffman.   

Abstract

In our experience, more than half of muscular dystrophy patients show a primary dystrophinopathy. The underlying cause of muscular dystrophy in the vast majority of patients with normal dystrophin is unknown. Recently, a French family with 4 young siblings showing a muscular dystrophy of unknown progression was shown to have a primary deficiency of "adhalin," the 50-kd dystrophin-associated protein. Here we report the screening of the entire adhalin coding sequence in muscle biopsy specimens from 30 muscular dystrophy patients to (1) determine whether adhalin deficiency is restricted to the French population, (2) determine the incidence of adhalin deficiency in muscular dystrophy patients, and (3) characterize the clinical features and mutations in adhalin-deficient patients. We identified a single African-American girl with childhood-onset muscular dystrophy and adhalin gene mutations. We found her to be a compound heterozygote for two different mutations of the same amino acid (Arg98Cys; Arg98His), one of which was previously identified in the French family. Our results suggest that primary adhalin deficiency in patients with muscular dystrophy but normal dystrophin is relatively infrequent, and that adhalin-deficient patients are not restricted to the French population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668821     DOI: 10.1002/ana.410380305

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation.

Authors:  E M McNally; M R Passos-Bueno; C G Bönnemann; M Vainzof; E de Sá Moreira; H G Lidov; K B Othmane; P H Denton; J M Vance; M Zatz; L M Kunkel
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

2.  Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D).

Authors:  A Carrié; F Piccolo; F Leturcq; C de Toma; K Azibi; C Beldjord; J M Vallat; L Merlini; T Voit; C Sewry; J A Urtizberea; N Romero; F M Tomé; M Fardeau; Y Sunada; K P Campbell; J C Kaplan; M Jeanpierre
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

Review 3.  Investigation of muscle disease.

Authors:  F L Mastaglia; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

4.  Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations.

Authors:  M Fanin; D J Duggan; M L Mostacciuolo; F Martinello; M P Freda; G Sorarù; C P Trevisan; E P Hoffman; C Angelini
Journal:  J Med Genet       Date:  1997-12       Impact factor: 6.318

5.  Forced expression of dystrophin deletion constructs reveals structure-function correlations.

Authors:  J A Rafael; G A Cox; K Corrado; D Jung; K P Campbell; J S Chamberlain
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

6.  The clinical spectrum and genetic variability of limb-girdle muscular dystrophy in a cohort of Chinese patients.

Authors:  Liang Wang; Victor Wei Zhang; Shaoyuan Li; Huan Li; Yiming Sun; Jing Li; Yuling Zhu; Ruojie He; Jinfu Lin; Cheng Zhang
Journal:  Orphanet J Rare Dis       Date:  2018-08-14       Impact factor: 4.123

7.  A novel DMD splicing mutation found in a family responsible for X-linked dilated cardiomyopathy with hyper-CKemia.

Authors:  Jin Tang; Xueqin Song; Guang Ji; Hongran Wu; Shuyan Sun; Shan Lu; Yuan Li; Chi Zhang; Huiqing Zhang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.